Iterum Therapeutics Plc (ITRMF)
0.079
+0.03
(+57.68%)
USD |
OTCM |
May 29, 16:00
Iterum Therapeutics Shareholders Equity (Quarterly) : -7.381M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 98.22M |
| Jazz Pharmaceuticals Plc | 4.532B |
| Perrigo Co. Plc | 2.499B |
| GH Research Plc | 263.38M |
| Cosmo Pharmaceuticals NV | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.50M |
| Total Liabilities (Quarterly) | 39.88M |
| Debt to Equity Ratio | -4.570 |
| Current Ratio | 2.135 |
| Net Debt Paydown Yield | -8.10% |